Home/Filings/4/0000899243-15-000568
4//SEC Filing

BAXTER INTERNATIONAL INC 4

Accession 0000899243-15-000568

$BAXCIK 0000010456operating

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 7:13 PM ET

Size

16.6 KB

Accession

0000899243-15-000568

Insider Transaction Report

Form 4
Period: 2015-07-01
Schabacker Marcus
CVP, Chief Scientific Officer
Transactions
  • Other

    Stock Option (Right to Buy)

    2015-07-01+43,59694,461 total
    Exercise: $37.38Exp: 2025-03-03Common Stock, par value $1 per share (43,596 underlying)
  • Other

    Common Stock, par value $1 per share

    2015-07-01+6,31124,459 total
  • Award

    Common Stock, par value $1 per share

    2015-07-01+5,00029,459 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $37.17Exp: 2024-03-04Common Stock, par value $1 per share (28,761 underlying)
    28,761
  • Stock Option (Right to Buy)

    Exercise: $37.82Exp: 2023-03-05Common Stock, par value $1 per share (27,062 underlying)
    27,062
Footnotes (7)
  • [F1]In connection with the spin-off (the "Spin-off") of Baxalta Incorporated ("Baxalta") from Baxter International Inc. ("Baxter"), the reporting person received a grant of 6,311 restricted stock units as a result of the adjustment of existing Baxter restricted stock units held by the reporting person prior to the Spin-off. These restricted stock units will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date.
  • [F2]The reporting person received a grant of 5,000 restricted stock units which will vest on July 1, 2018.
  • [F3]Represents options to purchase Baxter common stock awarded to the reporting person prior to the Spin-off. In connection with the Spin-off, the exercise price of the option was adjusted, and the reporting person received options to purchase shares of Baxalta common stock, to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.
  • [F4]Two-thirds of this option is presently exercisable. The remaining one third becomes exercisable on March 5, 2016.
  • [F5]One-third of this option is presently exercisable. The remaining two thirds become exercisable on March 4, 2016 and March 4, 2017.
  • [F6]In connection with the Spin-off, the number of shares subject to this option and the exercise price have been adjusted to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.
  • [F7]This option will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date of the existing option award.

Issuer

BAXTER INTERNATIONAL INC

CIK 0000010456

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000010456

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 7:13 PM ET
Size
16.6 KB